Barreteau, T.
Frey, S.
de Montrichard, M.
Dreant, A.
Budnik, T. Matysiak
Jacobi, D.
Perrot, B.
Blanchard, C. https://orcid.org/0000-0001-6801-7018
Article History
Received: 25 July 2024
Accepted: 11 October 2024
First Online: 4 November 2024
Declarations
:
: Drs Thomas Barreteau, Samuel Frey, Marie de Montrichard, Alexandre Dreant, Bastien Perrot, and Pr Tamara Matysiak-Budnik have no conflicts of interest or financial ties to disclose. Pr David Jacobi has an equity interest in participation on a Data Safety Monitoring Board, support for attending meetings and/or travel, payment for expert testimony, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, consulting fees, and grants or contracts from any entity with Eli Lilly, Amgen, Novo Nordisk, and Pfizer. Pr David Jacobi has a role of member of GCC-CSO in France. Pr Claire Blanchard has an equity interest in payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events with Gore, Medtronic, Johnson & Johnson, and Novonordisk.